Correlative biomarkers in a phase II study of dasatinib (D) and weekly (w) paclitaxel (P) for patients (Pts) with metastatic breast carcinoma (MBC).
2010 ◽
Vol 28
(15_suppl)
◽
pp. TPS124-TPS124
◽
Keyword(s):
Phase Ii
◽